A subgroup of breast cancer known as triple-negative breast cancer (TNBC) represents 15–20% of all breast cancers and is characterised by the lack of oestrogen receptor (ER) and progesterone receptor (PR) expression, in addition to the lack of human epidermal growth factor receptor (HER2) amplification. The gene discussed is PGR; the disease is triple-negative breast carcinoma.